Skip to content

Study · Measured the body's own peptide · 2020

1 result

F-Actin is associated with a worsening qSOFA score and intensive care unit admission in emergency department patients at risk for sepsis.

Belsky JB, Filbin MR, Rivers EP, Bobbitt KR, Jaehne AK, Wisnik CA, Maciejewski KR, Li F, Morris DC

Biomarkers : biochemical indicators of exposure, response, and susceptibility to chemicals1 Jun 2020Cited by 4 (Europe PMC)

PMID32421363 (opens in a new tab)DOI10.1080/1354750x.2020.1771419 (opens in a new tab)PepBankPUB-32421363
Source linkPubMedAsk about this study
Jump to 1 result

Summary

The text of this summary is not shown here, because the article license does not allow reuse. Read it at the source (opens in a new tab)

Text rights: Publisher copyright. Results still quote short attributed sentences.

Results from this study1

No result from this study comes from a test of the peptide.

Natural levels measured1

These results measure the body's own peptide. Nobody was given the peptide. They are not evidence about taking it. They are left out of key results, evidence counts and charts.

  1. 01HumanEndogenous levelObservational studyOther

    In emergency department patients at risk for sepsis, plasma Thymosin Beta‑4 was not associated with or predictive of any significant outcome measure.

    In plain wordsIn emergency patients at risk for sepsis, the body's own Thymosin Beta‑4 level was not linked to any significant outcome.

    Peptide
    Thymosin beta-4 (human)
    Outcome
    No significant changePlasma Tβ4 association with illness severity or outcomes
    Study

    n = 203

    Outcome group
    Intensive care and hospital outcomes · Infection

    Source sentences

    Summary
    Thymosin Beta 4 was not associated with or predictive of any significant outcome measures.
    2 context sentences
    Summary · context
    In this study of 203 ED patients, F-actin plasma levels had a linear trend of increase when the quick Sequential Organ Failure Assessment (qSOFA) score increased.
    Summary · context
    Prospective, biomarker study enrolling patients (>18 years) who met the Shock Precautions on Triage Sepsis rule placing them at-risk for sepsis.

    This result measures the body's own Thymosin beta-4 (human). Nobody was given the peptide. It is not evidence about taking it.

AI wrote and checked these results. AI can make mistakes, so check important results against the source.

Version history

PepBank keeps every version of the data on this study. Status changes from Retraction Watch, Europe PMC and Crossref are listed with their source.

  1. Version 2Current

    13 Oct 2026, 01:52 UTC

    Study results updated

  2. Version 1

    12 Oct 2026, 18:17 UTC

    First added · source update from Europe PMC

Subjects

Terms as the source lists them.

Publication types

PepBank is a research reference. Talk to a doctor before you use any peptide.